Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

Clinical trial NCT00412893 · COMPLETED

Trial details

NCT number: NCT00412893
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Aspergillosis Invasive Fungal Infection

Start date: 2007-03-07
Primary completion: 2013-03-28
Enrollment: 527

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.